Mohamed Elmeliegy

20PUBLICATIONS
36CO-AUTHORS
Pharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiologyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 17, 2026
Perspective on Pharmacokinetic Comparability for Biologics Development.

|Apr 29, 2026
Elranatamab: Mechanism of Action, Clinical, and Translational Science.

|Mar 02, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing Approach.

Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma

|Feb 13, 2026
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network.

Priya Jayachandran, Mayur K Ladumor, Georgios Vlasakakis

|Dec 17, 2025
Elranatamab Exposure-Safety Analysis in Relapsed or Refractory Multiple Myeloma.

Pooneh Soltantabar, Jennifer Hibma, Diane Wang

|Aug 18, 2025
Population Exposure-Response Efficacy Analysis of Elranatamab (PF-06863135) in Patients with Multiple Myeloma.

Hoi-Kei Lon, Jennifer Hibma, Sibo Jiang

Pageof 4

Frequent Collaborators

2 joint publications

Pooneh Soltantabar

1 joint publications

Derek Z Yang

1 joint publications

Neeraj Agarwal

1 joint publications

Arun Azad